innoVitroWe are happy to announce innoVitro’s CTO Peter Linder has been awarded the HESI (Health and Environmental Science Institute https://hesiglobal.org/) Cardiac Safety Committee Recognition Award 2022 – 2023 for his exceptional contributions to the Stem Cell Working Group.Continue readingCardiac Safety Committee Recognition Award 2022 -2023
innoVitro has been recognized by GHP (Global Health & Pharma) as most innovative in vitro technology company in Germany for the year 2022. Read the interview with Matthias Gossmann, CEO of innoVitro hereContinue readinginnoVitro awarded as most innovative in vitro technology company in Germany
Meet us virtually at the Safety Pharmacology Society Annual Meeting this year!Continue readingSeptember 14 – 17, 2020
Meet us virtually at the Advanced Therapies Congress & Expo this year!Continue readingSeptember 08 – 11, 2020
We are also offering our service on scientist.com.Continue readingscientist.com
